Jincong Q Freeman

21PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Digital health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 29, 2026
Accessible Clinical Tool for Prognosis and Chemotherapy Prediction in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in Diverse and Low-Resource Settings.

|May 18, 2026
Familial Disclosure and Cascade Testing in High-Risk Families is Influenced by Gene Variant Penetrance: Implications for Family based Breast Cancer Prevention.

|Dec 11, 2025
Skin Cancer Predisposition Genes, Full-Body Skin Examinations, Familial Disclosure, and Genetic Testing Among High-Risk Individuals.

Jincong Q Freeman, Yu Matsui, Fangyuan Zhao

|Oct 16, 2025
Factors Associated With Fear of Cancer Recurrence in a Multiethnic Cohort of Patients With Breast Cancer.

Armaan Jamal, Fangyuan Zhao, Jincong Q Freeman

|Sep 12, 2025
Clinical Outcomes and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Breast Cancer With Uncommon In Situ Hybridization Patterns or Discordant Immunohistochemistry.

Qianchen Zhang, Jincong Q Freeman, Fangyuan Zhao

|Aug 28, 2025
Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer.

Jincong Q Freeman, Rita Nanda, Frederick M Howard

Pageof 4

Frequent Collaborators

11 joint publications

Dezheng Huo

6 joint publications

Frederick Matthew Howard

5 joint publications

Rita Nanda

5 joint publications

Fangyuan Zhao